DXCM vs GEVO · P/E 63, rev $2.50B vs rev $89.4M
DexCom Inc (DXCM) versus Gevo Inc (GEVO) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Gevo Inc (GEVO) is a specialty chemicals company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported GEVO revenue for 2026-06-30 was $89.4M. Net income was -$198.6M. GEVO currently screens at market cap $378.5M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. GEVO currently screens at market cap $378.5M.
Not investment advice. Open the DXCM and GEVO stock pages for the full models.
Not investment advice.